BioVie to Host Live Investor Webinar and Q&A on Oct. 8
Provided By GlobeNewswire
Last update: Sep 26, 2025
CARSON CITY, Nev., Sept. 26, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, will host an investor webinar at 4:15 p.m. ET on Wednesday, Oct. 8, 2025.
Read more at globenewswire.com
